Skip to main content

3 Result(s)

within English Remove this filter Immunology Remove this filter W. Herr Remove this filter

and

  1. Article

    Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

    M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze… in Cancer Microenvironment (2015)

    Download PDF (180 KB) View Article

  2. Article

    Open Access

    Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

    Therapeutic options for patients with castration-resistant prostate cancer (CRPC) remain limited. In a multicenter, Phase II study, 65 patients with histologically confirmed CRPC received a biomodulatory regim...

    M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze… in Cancer Microenvironment (2015)

    Download PDF (951 KB) View Article

  3. No Access

    Chapter and Conference Paper

    Shared and Individual CTL-Defined Antigens on Human Melanoma Cells

    Cytolytic T Iymphocytes (CTL) have been shown to mediate immune protection and rejection responses in animal tumor models. T Iymphocytes recognize not intact proteins, but protein-derived peptides presented by...

    T. Wölfel, J. Schneider, M. Hauer, C. Wölfel, W. Herr in Symposium in Immunology VI (1997)